Differences in the Clinical and Hematological Characteristics of COVID-19 Patients with and without Type 2 Diabetes

Table 2

Clinical characteristics of patients with and without T2D infected with COVID-19.

Variables	NDM group ()	T2D group ()	value
Signs and symptoms at admission and treatment
Fever, (%)	36 (90.00%)	40 (100.00%)	0.13
Cough, (%)	33 (82.50%)	35 (87.50%)	0.77
Shortness of breath, (%)	16 (40.00%)	17 (42.50%)	0.10
Muscleache, (%)	20 (50.00%)	16 (40.00%)	0.55
Headache and mental disorder symptoms, (%)	12 (30.00%)	10 (25.00%)	0.79
Sore throat, (%)	13 (32.50%)	12 (30.00%)	0.89
Diarrhoea, (%)	5 (12.50%)	13 (32.50%)	0.03
Nausea and vomiting, (%)	7 (17.50%)	9 (22.50%)	0.80
More than one sign or symptom, (%)	32 (80.00%)	33 (82.50%)	0.98
Rate of secondary bacterial infection(suggested by procalcitonin), (%)	6 (15.00%)	13 (32.50%)	0.048
Chest X-ray and CT findings
Unilateral pneumonia, (%)	2 (5.00%)	0 (0.00%)	0.82
Bilateral pneumonia, (%)	38 (95.00%)	40 (100.00%)	0.40
No abnormal density shadow	0 (0.00%)

values indicate differences between T2D patients and NDM patients.  < .05 was considered statistically significant.